Atlas Trials

Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma

Clinical trial NCT02753543 · UNKNOWN

Trial details

NCT number
NCT02753543
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T Cell Lymphoma
Start date
2015-11-01
Primary completion
2018-11-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.